Martin JAKL
(University, Faculty of Medicine, Hradec Kralove-Czech, Republic)
Yıl: 2014Cilt: 14Sayı: 3ISSN: 1302-8723 / 1308-0032Sayfa Aralığı: 308 - 309İngilizce

40 0
The relationship between mean plate- let volume and high on-treatment platelet reactivity (Author`s Reply)
Fen > Tıp > Kalp ve Kalp Damar Sistemi
Dergititle.paper.letter_to_editorErişime Açık
  • 1. Jakl M, Sevcik R, Ceral J, Fatorova I, Horacek JM, Vojacek J. Mean platelet volume and platelet count: overlooked markers of high on-treatment platelet reactivity and worse outcome in patients with acute coronary syndrome.
  • 2. Lance MD, van Oerle R, Henskens YM, Marcus MA. Do we need time adjusted mean platelet volume measurements? Lab Hematol 2010; 16: 28-31. [CrossRef]
  • 3. Loreth RM, Klose G. Comparison of two different blood sample tubes for platelet function analysis with the Multiplate(R) system. Transfus Med Hemother 2010; 37: 289-92. [CrossRef]
  • 4. Slavka G, Perkmann T, Haslacher H, Greisenegger S, Marsik C, Wagner OF, et al. Mean platelet volume may represent a predictive parameter for over- all vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol 2011; 31: 1215-8. [CrossRef]
  • 5. Kandis H, Ozhan H, Ordu S, Erden I, Cağlar O, Başar C, et al. The prognostic value of mean platelet volume in decompensated heart failure. Emerg Med J 2011; 28: 575-8. [CrossRef]
  • 6. Arıkanoğlu A, Yücel Y, Acar A, Çevik MU, Akıl E, Varol S. The relationship of the mean platelet volume and C-reactive protein levels with mortality in ischemic stroke patients. Eur Rev Med Pharmacol Sci 2013; 17: 1774-7.
  • 7. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-207. [CrossRef]

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.